NewslettersImmunology of Infectious Disease NewsUncategorizedRobust Immune Responses Are Observed after One Dose of BNT162b2 mRNA Vaccine Dose in SARS-CoV-2 Experienced IndividualsBy Justin.choi - December 7, 20210252Scientists evaluated longitudinal immune responses to two-dose BNT162b2 mRNA vaccination in 15 adults who had experienced COVID-19, compared to 21 adults who did not have prior COVID-19.[Science Translational Medicine] 6445212 CCCCCCCC items 1 apa 0 default asc 1 169788 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article